Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 5, 2007, Pages 917-920

  Wen, Wanqing ^a   Ren, Zefang ^a   Xiao, Ou Shu ^a   Cai, Qiuyin ^a   Ye, Chuanzhong ^a   Gao, Yu Tang ^b   Zheng, Wei ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1;

ADULT; ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; ARYL HYDROCARBON HYDROXYLASES; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHINA; CONFIDENCE INTERVALS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 34250305827     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-1032     Document Type: Article

References (23)

1. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci U S A 1996;93:9776-81.
2. Liehr JG, Ricci MJ. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci U S A 1996;93:3294-6.
3. Guldberg HC, Marsden CA. Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 1975;7:419-4.
4. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol 2002;76:643-9.
5. Rylander-Rudqvist T, Wedren S, Granath F, et al. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk. Carcinogenesis 2003;24:1533-9.
6. Yim DS, Parkb SK, Yoo KY, et al. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 2000;11:279-86.
7. Wedren S, Rudqvist TR, Granath F, et al. Catechol-O- methyltransferase gene polymorphism and post-menopausal breast cancer risk. Carcinogenesis 2003;24:681-7.
8. Ahsan H, Chen Y, Whittemore AS, et al. A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat 2004;85:121-31.
9. Thyagarajan B, Brott M, Mink P, et al. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. Cancer Lett 2004;207:183-9.
10. Wen WQ, Cai Q, Shu XO, et al. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study and a meta-analysis. Cancer Epidemiol Biomarkers Prev 2005;14:329-35.
11. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003;43:309-34.
12. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 2000;87:295-300.
13. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast cancer disease. N Engl J Med 1985;312:146-51.
14. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999;28:964-74.
15. Royston P, Airman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling (with discussion). Appl Stat 1994;43:429-67.
16. Sauerbrei W, Royston P. Building multivariable prognostic and diagnostic models: transformation of the predictors using fractional polynomials. J R Stat Soc Ser A 1999;162:71-94.
17. Iscan M, Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O, Raunio H. The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat 2001;70:47-54.
18. Modugno F, Knoll C, Kanbour-Shakir A, Romkes M. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat 2003;82:191-7.
19. Singh S, Chakravarti D, Edney JA, et al. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma. Oncol Rep 2005;14:1091-6.
20. Wu MF, Wu WJ, Chang GC, et al. Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. Toxicol Lett 2004;150:211-9.
21. Tokizane T, Shiina H, Igawa M, et al. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 2005;11:5793-801.
22. Fitzgibbons PL, Henson DE, Hutter RV; Cancer Committee of the College of American Pathologists. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Arch Pathol Lab Med 1998;122:1053-5.
23. Harrmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-37.